(Q42242342)

19 October 2017

Structural and antigenic stability of H5N1 hemagglutinin trimer upon release from polyanhydride nanoparticles (English)

1 reference

19 October 2017

0 references

Kathleen A Ross

1

1 reference

19 October 2017

Hyelee Loyd

2

1 reference

19 October 2017

Wuwei Wu

3

1 reference

19 October 2017

Lucas Huntimer

4

1 reference

19 October 2017

Michael J Wannemuehler

5

1 reference

19 October 2017

Susan Carpenter

6

1 reference

19 October 2017

Balaji Narasimhan

7

1 reference

19 October 2017

4 February 2014

1 reference

Journal of Biomedical Materials Research Part A

19 October 2017

1 reference

19 October 2017

102

1 reference

19 October 2017

11

1 reference

19 October 2017

4161-4168

1 reference

Emerging respiratory viruses: challenges and vaccine strategies

19 October 2017

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

Oseltamivir resistance during treatment of influenza A (H5N1) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

A single immunization with soluble recombinant trimeric hemagglutinin protects chickens against highly pathogenic avian influenza virus H5N1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

Gastrointestinal delivery of baculovirus displaying influenza virus hemagglutinin protects mice against heterologous H5N1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

A universal epitope-based influenza vaccine and its efficacy against H5N1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

Design of a protective single-dose intranasal nanoparticle-based vaccine platform for respiratory infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

Single immunization with a suboptimal antigen dose encapsulated into polyanhydride microparticles promotes high titer and avid antibody responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

Role of polyanhydrides as localized drug carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

Toxicity, biodegradation and elimination of polyanhydrides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

Evaluation of polyanhydride microspheres for basal insulin delivery: Effect of copolymer composition and zinc salt on encapsulation, in vitro release, stability, in vivo absorption and bioactivity in diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

Salicylic acid-derived poly(anhydride-ester) electrospun fibers designed for regenerating the peripheral nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

Amphiphilic polyanhydrides for protein stabilization and release

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

Synthesis and characterization of novel polyanhydrides with tailored erosion mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

Microphase separation in bioerodible copolymers for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

Encapsulation, stabilization, and release of BSA-FITC from polyanhydride microspheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

Characterization of lentiviral pseudotypes with influenza H5N1 hemagglutinin and their performance in neutralization assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

Development and characterization of an equine infectious anemia virus Env-pseudotyped reporter virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

Gene transfer vectors derived from equine infectious anemia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

The role of microsphere fabrication methods on the stability and release kinetics of ovalbumin encapsulated in polyanhydride microspheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

Effect of polymer chemistry and fabrication method on protein release and stability from polyanhydride microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

Physicochemical studies on the stability of influenza haemagglutinin in vaccine bulk material

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

Protein stability in the presence of polymer degradation products: consequences for controlled release formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.35086

21 January 2018

Identifiers

DOI

10.1002/JBM.A.35086

1 reference

19 October 2017

1 reference